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Abstract
Background: Early and rapid detection of dengue virus (DENV) infection during the febrile period is crucial for
proper patient management and prevention of disease spread. An easy to perform and highly sensitive method is
needed for routine implementation especially in the resource-limited rural healthcare settings where dengue
is endemic.
Methods: A single-tube reverse transcription-loop-mediated isothermal amplification (RT-LAMP) assay with a set
of nine primers was developed for the detection of all four DENV serotypes and their different genotypes. The
sensitivity and specificity of the RT-LAMP were evaluated. The clinical applicability of RT-LAMP assay for detection of
DENV RNA was assessed in a total of 305 sera of clinically-suspected dengue patients. The test results of RT-LAMP
were statistically compared to those of quantitative reverse transcription-polymerase chain reaction (qRT-PCR),
IgM- and IgG-capture enzyme-linked immunosorbent assays (ELISA).
Results: Acute DENV infection was confirmed in 171 samples (n = 305); 43.3% (74/171) and 46.8% (80/171) of the
samples were positive for DENV using RT-LAMP and qRT-PCR, respectively. The combination of RT-LAMP with the
dengue IgM and IgG ELISA increased detection of acute DENV infection to 97.7% (167/171), in comparison to only
70.8% (121/171) when dengue IgM and IgG ELISA alone were used. The RT-LAMP assays showed high concordance
(κ = 0.939) with the qRT-PCR. The RT-LAMP assay detected up to 10 copies of virus RNA within an hour but 100%
reproducibility (12/12) was achieved with 100 copies. There was no cross reactivity of RT-LAMP with other closely
related arboviruses.
Conclusion: The RT-LAMP assay developed in this study is sensitive, specific and simple to perform. The assay
improved the detection of dengue when used in combination with serological methods.
Background
Dengue virus (DENV) is a positive-sense single-stranded
RNA virus with a genome of ~10.7 kb in length [1].
There are four antigenically distinct DENV serotypes;
DENV-1, DENV-2, DENV-3 and DENV-4 [2] and each
serotype contains phylogenetically distinct genotypes [3].
Infection with any of the four serotypes produces a
spectrum of clinical illness ranging from mild dengue
fever (DF) to severe and fatal dengue hemorrhagic fever
(DHF) and hemorrhagic shock syndrome (DSS) [4].
Infection with one serotype leads to lifelong protection
against homotypic reinfection but only temporary cross-
protection against heterotypic infection [5]. Studies have
shown that heterotypic secondary infection is associated
with higher risk of contracting DHF and DSS [6] possibly
through antibody-dependent enhancement [7,8], original
antigenic sin [9,10], cytokine storm [11], or autoimmune
response [12,13]. Currently, an estimated 3.6 billion per-
sons living in dengue-endemic countries are at risk of
contracting dengue [14]. Viremic individuals are the main
source of infectious virus. Virus is transmitted following
mosquito bites of these viremic individuals. A sensitive,
easy to perform and rapid method for detection of DENV
in viremic febrile patients is therefore of paramount
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importance especially for patient management and imme-
diate vector control measures to prevent large-scale epi-
demic [15].
Routine laboratory diagnosis of DENV infection in
most resource-limited countries is based on the detec-
tion of virus-specific antibodies as well as virus isolation.
Detection of viral components such as non-structural
protein 1 (NS1) and virus genomic RNA are done but
mostly in referral or in more well-funded diagnostic la-
boratories [16-18]. Although virus isolation in C6/36
mosquito cell line has been considered as the “gold
standard” for DENV detection, it is costly and time-
consuming as more than 7 days is required to complete
the assay [19,20]. IgM- and IgG-capture enzyme-linked
immunosorbent assays (ELISA) are the most widely used
methods to infer DENV infection serologically [21].
However, it requires second convalescent sera for con-
firmation of test results. It is also not useful during the
febrile viremic phase of the infection when there is yet
no significant rise in the antibody titers. In addition,
antibody cross-reactivity towards other closely related
flaviviruses is a common problem [16]. DENV NS1
ELISA, the other known dengue test, is highly sensitive
and specific [22,23] but it can be compromised by pre-
existing NS1-IgG immunocomplexes in the acute stage
of secondary DENV infection, which is common in den-
gue endemic region [24-27]. More recently, molecular
techniques to detect virus genomic RNA sequence by re-
verse transcription-polymerase chain reaction (RT-PCR)
and real-time quantitative RT-PCR (qRT-PCR) are grad-
ually being accepted as new standards over virus isola-
tion for the detection of DENV in acute sera [28-32].
The method is highly useful for detection of virus in
viremic individuals. The requirement of costly nucleic
acid amplification instrument and high level of skill,
however, has restricted the application of these methods
especially in resource-limited rural healthcare settings.
The loop-mediated isothermal amplification (LAMP)
of genomic sequence is a novel method for the detection
of nucleic acid with high specificity and sensitivity with-
out the need of specialized equipment [33-35]. The
method requires only a heating block or water bath that
can maintain constant temperature between 60 to 65°C
as the nucleic acid amplification reaction can be per-
formed at a single constant temperature. It has been de-
scribed for the detection of various infectious agents
including DENV [36-38]. These earlier reports, however,
evaluated their RT-LAMP assays for the detection of
DENV infection with a small clinical sample size (<100)
and using the C-prM gene [38] or serotype-specific re-
gions of the 3′ untranslated region (UTR) [36,37] as the
amplification targets. In the present study, we described
an improved method for the development and applica-
tion of the RT-LAMP assay for the detection of DENV
infection in freshly obtained dengue-suspected patient
samples in actual clinical laboratory setting of a hospital
in dengue endemic environment.
Methods
Dengue viruses
A total of 11 reference DENV strains (four strains
of DENV-1, genotype I, II, III and sylvatic; two strains
of DENV-2, Asian I and cosmopolitan; three strains of
DENV-3, genotype I, II and III; two strains of DENV-4,
subgenotype IIa and IIb) were used in this study
[30,39-41]. All the viruses were archived in the University
Malaya Medical Centre (UMMC) Diagnostic Virology La-
boratory repository. The isolates at passage 1 were used to
inoculate C6/36 (Aedes albopictus) mosquito cells for one
week and virus RNA was extracted from the infected cell
culture supernatant.
Clinical samples
The study obtained ethics approval from the UMMC
Medical Ethics Committee (Ethics Committee/IRB Ref-
erence Number: 908.11). The study was conducted dur-
ing the period from October to December 2012. A total
of 305 serum samples from patients clinically suspected
with DENV infection were obtained. All clinical samples
were taken as part of standard patient care. The samples
were divided in the laboratory to be used for routine
diagnosis by serological assays and evaluation of the RT-
LAMP assay developed in this study.
RNA extraction
Total RNA was extracted from 140 μl of infected culture
supernatant or patient serum samples using QIAamp
Viral RNA Mini Kit (Qiagen, Germany), following the
manufacturer’s protocol. All RNA extraction was done
manually. The RNA was eluted in 60 μl of nuclease-free
water and stored at −80°C until needed.
Design of DENV-specific RT-LAMP assay primers
The DENV-specific primers used for RT-LAMP assay
were designed from the 3′UTR of the DENV genome.
The 3′UTR nucleotide sequences of each DENV sero-
types were retrieved from GenBank. Multiple sequence
alignment of the 3′UTR sequences was performed using
Clustal X 2.0 [42]. A set of nine primers comprising four
outer, four inner, and one loop primers that recognize
seven distinct regions on the target sequence was
designed according to the criteria described by Notomi
et al. [33] (Table 1 and Additional file 1). The coverage
of the RT-LAMP primers was validated by evaluating
the assay using viral RNA extracted from the different
DENV strains, as described above.
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RT-LAMP assay
The RT-LAMP was performed in a final reaction volume
of 25 μl using a Loopamp RNA Amplification Kit (Eiken
Chemical Co. Ltd., Japan) added with 20 pmol each of
inner primers FIP/123, FIP/4, BIP/123, and BIP/4; 2.5
pmol each of outer primers F3/134, F3/2, B3/123, and B3/
4; 20 pmol of loop primer BLP/1234; 1 μl of Fluorescent
Detection Reagent (Eiken Chemical Co. Ltd., Japan); and
5 μl of the extracted RNA template. A positive control
using 1000 copies (determined by qRT-PCR) of DENV
RNA extracted from culture supernatant and a negative
control (nuclease-free water) were included in each run.
The RT-LAMP reactions were incubated at 63°C for
80 min and inactivated at 80°C for 5 min in LA-500
Loopamp real-time turbidimeter (Eiken Chemical Co.
Ltd., Japan). The turbidity of RT-LAMP reaction was spec-
trophotometrically recorded at 650 nm every 6 s. The
threshold time (Tt) value for positivity by RT-LAMP was
determined when the turbidity increased above the thresh-
old value, which was fixed at 0.07 absorbance units. The
RT-LAMP amplification was also visually monitored for
color change. Positive reaction turned the reaction mix
green and fluoresces under the white light and UV irradi-
ation, respectively. The reaction mix remained orange and
non-fluorescent in the absence of amplification.
Specificity of RT-LAMP assay
The specificity of the RT-LAMP amplification was
assessed by single site restriction enzyme digestion of the
amplified DNA fragments using BanII [36]. Following
overnight digestion at 37°C, the undigested and digested
RT-LAMP-amplified DNA fragments were electropho-
resed on a 2% agarose gel in Tris-acetate-EDTA buffer.
The gel was stained with GelRed (Biotium Inc., US) and
visualized using a Gel Doc 2000 (Bio-Rad Laboratories,
Inc., US). The digested DNA fragments were sequenced
using the loop primer BLP/1234. The specificity of the
DENV RT-LAMP primers was evaluated against another
three closely related arboviruses common in the region;
Japanese encephalitis virus (JEV), Chikungunya virus
(CHIKV), and Sindbis virus (SINV).
Sensitivity of RT-LAMP assay
The sensitivity of RT-LAMP assay was assessed using a
panel of serially diluted viral RNA (1000, 100, 60, and 10
copy numbers) extracted from culture supernatant. The
sensitivity test of RT-LAMP was repeated twelve times.
The viral RNA used was quantitated using the genesig
Real-Time qRT-PCR DENV Detection Kit (PrimerDesign
Ltd., UK). The qRT-PCR assay standard plot, ranged from
10 to 106 RNA copies, was made by preparing a 10-fold
serial dilution of the genesig DENV RNA standard. The
genesig DENV RNA standard was a synthetic RNA tem-
plate with known copy number. The qRT-PCR was
performed in a final volume of 20 μl containing 10 μl of
real time master mix, 1 μl of probe/primer mix, 4 μl of
nuclease-free water, and 5 μl of diluted RNA. Quantitative
PCR measurement was performed using StepOnePlus real
time PCR system (Applied Biosystems, USA) according to
the following condition: 10 min at 55°C, 8 min at 95°C
followed by 50 cycles of amplification (10 s at 95°C, 60 s at
60°C). Raw data was analyzed with StepOne Software
v2.2.1 to determine copy number based on the threshold
cycles (Ct). The efficiency of the qRT-PCR was measured
from the slope of standard curve.
Evaluation of RT-LAMP assay
The clinical applicability of a single-tube RT-LAMP assay
for detection of DENV RNA was assessed in a total of 305
serum samples freshly obtained from dengue-suspected pa-
tients. The qRT-PCR, as described above, was used as a
reference assay for the detection of DENV RNA in the
samples. In addition, the samples were simultaneously
screened for the presence of anti-dengue IgM using the SD
Dengue IgM Capture ELISA kit (Standard Diagnosis Inc.,
Korea). The IgM-negative samples were further screened
for the presence of anti-dengue IgG using the SD Dengue
IgG Capture ELISA kit (Standard Diagnosis Inc., Korea).
The test results of RT-LAMP, qRT-PCR, and ELISA were
compared. Acute DENV infection was confirmed by the
positive detection of anti-DENV IgM by ELISA and/or the
presence of DENV RNA detected by qRT-PCR assay.
Serum sample tested positive only for anti-DENV IgG was
identified as indicative of past DENV infection.
In this study, the results obtained by molecular diagnosis
of dengue were not used for the standard patient care as
the molecular assay was still being developed. The qRT-
Table 1 RT-LAMP primers used for the rapid detection of
DENV














aF3 forward outer primer, B3 backward outer primer, FIP forward inner primer,
BIP backward inner primer, BLP backward loop primer.
bNumber (1–4) after the slash (/) represents DENV serotype (e.g. F3/134,
forward outer primer for DENV-1, -3 and −4).
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PCR was used only as research tool in the reference labora-
tory. Currently, only the serological methods were approved
for routine clinical diagnosis of dengue at the UMMC.
Statistical analysis
All statistical analysis was performed using IBM SPSS
Statistics, version 21 (IBM Corporation, New York, United
States). The degree of agreement between RT-LAMP and
qRT-PCR test results was measured by kappa value (κ).
Chi-square test (McNemar’s exact test, two-tailed) was
performed to evaluate and compare the sensitivity of all
molecular and serological methods used. In the present
study, the p-value <0.001 was used to suggest significant
results. The diagnostic performance of RT-LAMP assay
as compared to qRT-PCR was calculated using web-
based CEBM Statistics Calculator (http://ktclearinghouse.
ca/cebm/toolbox/statscalc).
Results
Design of DENV-specific RT-LAMP assay primers
In order to develop the single-tube RT-LAMP assay for
detection of all four DENV serotypes, a set of nine primers
comprising four outer (F3/134, F3/2, B3/123, and B3/4),
four inner (FIP/123, FIP/4, BIP/123, and BIP/4), and one
loop primers (BLP/1234) were designed. This was done
using the alignment of the conserved 3′UTR regions of
DENV genome (Table 1 and Additional file 1). Results
shown in Figure 1 suggested that the RT-LAMP primers
detected the entire panel of 11 available reference DENV
strains.
Specificity of RT-LAMP assay
No cross-reactivity of the RT-Lamp assay was observed
with all other three closely related arboviruses common
in the region, including JEV, CHIKV and SINV (Figure 1).
Figure 1 Visual observation of fluorescence in RT-LAMP reactions under UV light. Tube 1, negative control; tube 2–5, DENV-1 genotype I, II,
III and sylvatic, respectively; tube 6–7, DENV-2 Asian I and cosmopolitan, respectively; tube 8–10, DENV-3 genotype I, II and III, respectively; tube
11–12, DENV-4 subgenotype IIa and IIb, respectively; tube 13–15, JEV, CHIKV and SINV, respectively.
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The specificity of the assay was also verified by restric-
tion enzyme BanII digestion on the amplified DNA frag-
ments of all four DENV serotypes. As shown in Figure 2,
the undigested and digested DNA fragments were ob-
served as ladder-like and two-band patterns, respectively
[36,37]. The sizes of the digested DNA fragments were
in agreement with the expected size for each serotype;
129 bp and 233 bp for DENV-1, 135 bp and 231 bp for
DENV-2, 129 bp and 231 bp for DENV-3, as well as
141 bp and 231 bp for DENV-4. Nucleotide sequencing
of the 231 bp and 233 bp digested DNA fragments con-
firmed that the RT-LAMP amplified nucleotide se-
quences were specific to DENV (data not shown).
Sensitivity of RT-LAMP assay
The sensitivity of RT-LAMP assay was determined by re-
peated independent testing on a panel of serially diluted
viral RNA extracted from culture supernatant with known
copy number (Figure 3). The number of positive detection
by RT-LAMP assays (n = 12) for the DENV RNA with
copy numbers of 1000, 100, 60, and 10 were 100% (12 of
12), 100% (12 of 12), 75% (9 of 12), and 25% (3 of 12),
respectively, with the mean time threshold (Tt) of 46.97 ±
2.28 min, 53.67 ± 1.77 min, 53.78 ± 2.89 min, 53.28 ±
5.04 min, respectively. The RT-LAMP assay detected up
to 10 copies of RNA but 100% (12 of 12) reproducibility
was achieved with at least 100 copies of RNA.
Evaluation of RT-LAMP assay
The RT-LAMP assay for detection of DENV RNA was
evaluated by testing on a total of 305 fresh serum sam-
ples of clinically dengue-suspected patients. The findings
of RT-LAMP were compared to those obtained by qRT-
PCR. Of the 305 samples, 282 were first serum samples
while 23 were second samples collected at 1 to 5 days
from the first sample. Out of 305 samples, acute dengue
infection was confirmed in 171 (56.1%) by either qRT-
PCR or dengue IgM ELISA, or both (Table 2). Five out
of the 171 samples (2.9%) were identified as secondary
DENV infection as virus RNA and dengue-specific IgG
were detected in the absence of dengue IgM. Seven sam-
ples were identified as past DENV infection as only den-
gue IgG was tested positive.
The diagnostic performance of the RT-LAMP in com-
parison with qRT-PCR assay is summarized in Table 3.
The RT-LAMP assay detected DENV genome in 74 of
171 (43.3%) of the acute dengue samples compared to
Figure 2 Confirmation of RT-LAMP amplification of DENV.
Restriction enzyme digestion of DENV-specific RT-LAMP-amplified
DNA fragments were performed using BanII. The DNA fragments
were separated on a 2% agarose gel. Lane M, 100-bp plus DNA
ladder; lane 1, DENV-1 RT-LAMP assay amplification; lane 2, BanII
digestion of DENV-1 RT-LAMP-amplified DNA fragments, 129 bp and
233 bp; lane 3, DENV-2 RT-LAMP assay amplification; lane 4, BanII
digestion of DENV-2 RT-LAMP-amplified DNA fragments, 135 bp and
231 bp; lane 5, DENV-3 RT-LAMP assay amplification; lane 6, BanII
digestion of DENV-3 RT-LAMP-amplified DNA fragments, 129 bp and
231 bp; lane 7, DENV-4 RT-LAMP assay amplification; lane 8, BanII
digestion of DENV-4 RT-LAMP-amplified DNA fragments, 141 bp
and 231 bp.
Figure 3 Time threshold of positivity for RT-LAMP assays of
serially diluted DENV RNA. The mean of Tt-values was calculated
with available positive results out of twelve replicates. Error bars
indicate the standard deviations of Tt-values from the mean.
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80 of 171 (46.8%) by qRT-PCR assay (Table 2). These
two methods, however, showed high concordance with
kappa value of 0.939 (p < 0.001). DENV RNA was tested
negative in 6 samples by RT-LAMP but positive by qRT-
PCR. All of these samples contained <50 copies of RNA
per reaction (Figure 4). In this study, one sample that
was tested positive by RT-LAMP but negative by qRT-
PCR or serological methods was considered as false
positive. The combination of RT-LAMP with the dengue
IgM and IgG ELISA resulted in a significant increase
(p < 0.001) in sensitivity to 97.7% (167 of 171) in com-
parison to using dengue IgM and IgG ELISA alone
which had sensitivity of 70.8% (121 of 171) (Figure 5).
Discussion
In the present study, a single-tube RT-LAMP assay was
developed with a set of nine primers targeted at the highly
conserved regions of DENV 3′UTR of the reported global
DENV strains. We demonstrated that the RT-LAMP assay
detected a panel of DENV strains from different DENV ge-
notypes circulating in Malaysia and many other dengue
endemic countries in Southeast Asia [30,39-41]. There
was no cross reactivity of RT-LAMP with other closely re-
lated arboviruses. The RT-LAMP assay was as sensitive as
the qRT-PCR for DENV detection in the viremic serum
samples. In this study, the RT-LAMP assay is positioned
as a complementary tool for the routine serology test in a
reference diagnostic laboratory.
The RT-LAMP assay developed here differs from those
reported earlier in at least two major areas [36-38]. Parida
et al. (2005) developed a four-tube RT-LAMP assay which
employed serotype-specific primers targeting the proximal
half of the 3′UTR of DENV genome [36]. The four-tube
reaction system required four separate reactions to be
performed for each sample. Therefore, it is not cost-
effective for routine diagnosis particularly in the hospital
setting where the interest is simply in knowing if the pa-
tient has dengue. Recently, Lu et al. developed a single-
tube reaction system for the detection of DENV infection
using RT-LAMP primers derived from the C-prM gene
[38]. The C-prM gene, however, was relatively less con-
served among all four DENV serotypes (inter-serotype) in
comparison to the 3′UTR (unpublished data). Thus, the
primers designed based on the C-prM gene may not give
a good coverage for all four DENV serotypes and their ge-
notypes. In many dengue hyperendemic countries, mul-
tiple DENV genotypes of all four serotypes co-circulate
[30,39-41]. In our study, we used the combination of
primers targeting the highly conserved region of DENV 3′
UTR. The nine primers were generated to be useful to
Table 2 Summary of dengue detection in serum samples from clinically dengue-suspected patients in UMMC using
RT-LAMP, qRT-PCR, IgM and IgG ELISA
IgM ELISA IgG ELISAb
Positive Negative Positive Negative Not-tested
Assays Resultsc n (%) n (%) n (%) n (%) n (%)
RT-LAMP Positive 23 (30.7) 52 (69.3) 5 (6.7) 40 (53.3) 30 (40.0)
(n = 75d)
Negative 93 (40.4) 137 (59.6) 7f (3.1) 130 (56.5) 93 (40.4)
(n = 230)
qRT-PCR Positive 25a (31.3) 55a (68.7) 5 (6.3) 43 (53.7) 32 (40.0)
(n = 80e)
Negative 91a (40.4) 134 (59.6) 7f (3.1) 127 (56.5) 91 (40.4)
(n = 225)
aAcute DENV infection was confirmed in 171 samples.
bDengue IgG ELISA was only performed on 182 (out of 189) dengue IgM negative samples.
cAgreement of results between RT-LAMP and qRT-PCR, κ = 0.939.
dOne of RT-LAMP positive samples were tested negative by qRT-PCR
eSix of qRT-PCR positive samples were tested negative by RT-LAMP.
fDENV RNA was tested negative by both RT-LAMP and qRT-PCR in 7 samples.
Table 3 Diagnostic performance of RT-LAMP assay against qRT-PCR assay in serum samples from clinically
dengue-suspected patients in UMMC
qRT-PCR Sensitivity% (95%CI) Specificity% (95% CI) PPV% (95% CI) NPV% (95% CI)
Assay Results Pos Neg
RT-LAMP Pos 74 1 92.5 (84.6-96.5) 99.6 (97.5-99.9) 98.7 (92.8-99.8) 97.4 (94.4-98.8)
Neg 6 224
PPV positive predicted value, NPV negative predicted value, CI confidence interval, Pos positive, Neg negative.
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accommodate the viral diversity present in the region. We
showed here that all the 11 different reference DENV
strains from 10 DENV genotypes were detected with the
RT-LAMP primers designed in the study.
The RT-LAMP assay developed in this study has a
detection limit of at least 100 copies of viral RNA
(Figure 3). We defined the detection limit in this study
as the lowest amount of template detectable with 100%
reproducibility throughout the repeated testing. Other
similar studies have reported detection limit of lower
than 100 copies but with lack of information on the
confidence level [37,38]. Our RT-LAMP assay was able
to detect up to as few as 10 copies of viral RNA, but
with reduced reproducibility. The viral load was in-
versely proportional to the antibody titer according to
the day of onset of fever. Low viral load (<100 viruses) is
usually accompanied with the rise of antibody titer
[43,44]. The detection of DENV using RT-LAMP regard-
less of the viral load could be completed within 1 hour
making the assay a rapid tool for early dengue diagnosis.
Here, the RT-LAMP assay for DENV detection was
prospectively evaluated for the first time with a large
number of clinical serum samples (n = 305) from
dengue-suspected patients. The performance of the RT-
LAMP assay was validated by simultaneous testing of
the samples using real time qRT-PCR, which is known
as the most sensitive and specific method for the detec-
tion of viral RNA [45]. In our study, both the RT-LAMP
and qRT-PCR assays showed comparable sensitivity for
the detection of DENV in patients’ sera (κ = 0.939), even
though the sensitivity of RT-LAMP was slightly lower
than that of qRT-PCR. Similar findings have been
reported in several other studies for the evaluation of
LAMP assay when compared against the qPCR [46,47].
The RT-LAMP assay in this study gave possibly six false
negative and one false positive results. The false negative
detection could be caused by low viral load, below the
detection limit of RT-LAMP. However, this could also
reflect false positive detection of the qRT-PCR. This
could be verified by culturing the samples for virus isola-
tion. Similarly, the false positive RT-LAMP result could
be a true positive but need to be verified by virus
isolation.
Currently, in most dengue endemic region where re-
sources are limited, early diagnosis of dengue relies very
much on the clinical presentations. A number of other in-
fections, however, can present with almost similar features
especially during the early febrile phase. Rapid confirm-
ation of dengue is important to ensure proper manage-
ment of patients and appropriate outbreak prevention
measures. Currently, serological assay is the most com-
mon method used to confirm DENV infection. In our
study, using actual clinical samples when febrile dengue
patients first visit to the hospital, 46.8% (80 of 171) of the
specimen received indicated that the patients were viremic
with the absence of IgM or IgG (Figure 5). The RT-LAMP
or qRT-PCR, when used in combination with ELISA, in-
creased the diagnostic coverage of febrile dengue patient
to more than 97%. The early detection of viremic individ-
uals allows for immediate intervention to prevent further
spread of dengue by encouraging the patient to take pre-
caution to prevent from mosquito bites. In addition, it al-
lows the patient to have sufficient warning to immediately
come back to hospital if warning signs of impending se-
vere dengue develops.
Figure 4 Number of clinical samples positive by RT-LAMP and
qRT-PCR. Six samples were tested positive for DENV RNA by qRT-
PCR but negative by RT-LAMP. One sample positive by RT-LAMP but
negative by qRT-PCR was excluded.
Figure 5 Sensitivity of dengue diagnostic methods against
laboratory-confirmed dengue samples (n = 171). Sensitivity
between groups was compared using McNemar’s exact
test (two-tailed).
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Conclusions
The RT-LAMP assay developed in our study showed
high sensitivity and specificity comparable to qRT-PCR
for detection of DENV in clinical samples. The single-
tube RT-LAMP assay utilized a primer set with coverage
for all the reported DENV strains particularly those
common in the region. Implementation of the RT-
LAMP assay into routine dengue diagnosis to comple-
ment the antibody detection would greatly enhance the
diagnostic coverage of suspected dengue cases without
the need for costly equipment and reagents. The RT-
LAMP assay developed in this study is sensitive, specific
and simple to perform, and in combination with the
ELISA is a promising detection tool for early dengue
diagnosis in rural clinics and field situation where re-
sources are limited.
Additional file
Additional file 1: Figure S1. Map of RT-LAMP primers in alignment
with the DENV 3’UTR consensus sequences. The arrows indicate the
orientation of primers in 5′ to 3′ direction.
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